Integrum AB (publ)

Stockholm Stock Exchange INTEG-B.ST

Integrum AB (publ) Revenue for the year ending April 30, 2024: USD 9.42 M

Integrum AB (publ) Revenue is USD 9.42 M for the year ending April 30, 2024, a 30.66% change year over year. Revenue is the total amount of money generated from the sales of goods or services by a company during a specific period.
  • Integrum AB (publ) Revenue for the year ending April 30, 2023 was USD 7.21 M, a 27.63% change year over year.
  • Integrum AB (publ) Revenue for the year ending April 30, 2022 was USD 5.65 M, a 11.50% change year over year.
  • Integrum AB (publ) Revenue for the year ending April 30, 2021 was USD 5.07 M, a 85.58% change year over year.
  • Integrum AB (publ) Revenue for the year ending April 30, 2020 was USD 2.73 M, a 15.96% change year over year.
Key data
Date Revenue Gross Profit Operating Income EBIT
Market news
Loading...
Stockholm Stock Exchange: INTEG-B.ST

Integrum AB (publ)

CEO Mr. Scott D. Flora
IPO Date May 15, 2017
Location Sweden
Headquarters Krokslätts Fabriker 50
Employees 36
Sector Health Care
Industries
Description

Integrum AB (publ) researches, develops, and sells various systems for bone-anchored prostheses. The company provides Osseointegrated Prostheses for the Rehabilitation of Amputees (OPRA) implant systems, a bone-anchored prostheses system based on osseointegration, where the prostheses are directly attached to the bone, avoiding the use of socket. The OPRA implant system offers protection to the patient by avoiding bone fractures from accidental loads. The company also provides Neuromotus, a technology that is used for therapy to reduce phantom limb pain after an amputation. It sells its implant systems to hospitals, clinics, and orthopedists worldwide. The company was founded in 1962 and is headquartered in Mölndal, Sweden.

Similar companies

CRAD-B.ST

C-Rad AB (publ)

USD 2.57

-0.02%

BONEX.ST

Bonesupport Holding AB (publ)

USD 32.97

-0.61%

BIOVIC-B.ST

Biovica International AB (publ)

USD 0.16

-0.98%

CANTA.ST

Cantargia AB (publ)

USD 0.15

0.09%

SUS.ST

Surgical Science Sweden AB (publ)

USD 13.49

0.81%

StockViz Staff

January 15, 2025

Any question? Send us an email